AN2 Therapeutics Grants Inducement Equity Awards to Two New Employees

• AN2 Therapeutics granted equity awards to two newly hired employees on October 19, 2026.
• The awards comprise non-qualified stock options covering 10,565 common shares and 5,283 restricted stock units.
• The grants fall under the 2026 Employment Inducement Award Plan.
• Options vest 25% on the vesting commencement date’s first anniversary, then 1/48th monthly on the same day of the month.
• Restricted stock units vest annually over four years, subject to continuous service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261023571727) on October 23, 2026, and is solely responsible for the information contained therein.